Central nervous system big money
Central nervous system (CNS) treatments are big business – and are growing at the fastest rate among the largest therapeutic categories. The global sales of CNS therapeutics are second only to those sold for cardiovascular ailments.
One of the fastest growing markets is in treatments for multiple sclerosis, which grew by 21 percent in 2002. Due to a frustrating history of ineffective MS treatments, doctors and patients are embracing these biotech innovations.